These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 18377797)

  • 41. Etiology and risk factors for oesophageal adenocarcinoma: possibilities for chemoprophylaxis?
    Lagergren J
    Best Pract Res Clin Gastroenterol; 2006; 20(5):803-12. PubMed ID: 16997162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current challenges in Barrett's esophagus.
    Falk GW
    Cleve Clin J Med; 2001 May; 68(5):415-7, 422-4. PubMed ID: 11352321
    [No Abstract]   [Full Text] [Related]  

  • 45. Mechanisms of esophageal adenocarcinoma formation and approaches to chemopreventive intervention.
    Richmond E; Umar A
    Semin Oncol; 2016 Feb; 43(1):78-85. PubMed ID: 26970126
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent developments in esophageal adenocarcinoma.
    Lagergren J; Lagergren P
    CA Cancer J Clin; 2013; 63(4):232-48. PubMed ID: 23818335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insights Into the Pathophysiology of Esophageal Adenocarcinoma.
    Quante M; Graham TA; Jansen M
    Gastroenterology; 2018 Jan; 154(2):406-420. PubMed ID: 29037468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Gastroesophageal reflux disease and Helicobacter pylori infection].
    Naumovski-Mihalić S; Sabarić B; Filipec T; Tićak M; Prskalo M; Skurla B; Papa B; Dominis M; Katicić M
    Lijec Vjesn; 2002 Sep; 124 Suppl 1():52-6. PubMed ID: 12592818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barrett's oesophagus and carcinoma. Recent insights into its development and possible prevention.
    Peters FT; Kleibeuker JH
    Scand J Gastroenterol Suppl; 1993; 200():59-64. PubMed ID: 8016573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemoprevention of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Bresalier RS
    Dig Dis Sci; 2018 Aug; 63(8):2155-2162. PubMed ID: 29948566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
    Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
    Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemoprevention of adenocarcinoma associated with Barrett's esophagus: potential options.
    Neumann H; Mönkemüller K; Vieth M; Malfertheiner P
    Dig Dis; 2009; 27(1):18-23. PubMed ID: 19439956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastroesophageal Reflux Disease Is Not a Great Screening Criterion: Time to Move on to Other Strategies for Controlling the Burden of Esophageal Adenocarcinoma.
    Rubenstein JH
    Am J Gastroenterol; 2022 Nov; 117(11):1759-1761. PubMed ID: 36327434
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastroesophageal reflux disease. Are we acting in the best interest of our patients?
    Tebala GD
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4553-4556. PubMed ID: 27874941
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The columnar-lined (Barrett's) esophagus. Can progression to cancer be prevented?
    Stollman N
    Postgrad Med; 2000 Jun; 107(7):59-65; quiz 216. PubMed ID: 10887445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett's esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population.
    Realdon S; Antonello A; Arcidiacono D; Dassie E; Cavallin F; Fassan M; Nardi MT; Alberti A; Rugge M; Battaglia G
    Eur J Nutr; 2016 Jun; 55(4):1563-71. PubMed ID: 26155779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Gastro-Esophageal Reflux Disease and Malignant Progression - Equal Risk for Men and Women?].
    Pech O
    Laryngorhinootologie; 2016 Dec; 95(12):828-830. PubMed ID: 29301150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk factors for erosive and non-erosive gastroesophageal reflux disease and Barrett's esophagus in Nothern Sardinia.
    Dore MP; Pes GM; Bassotti G; Farina MA; Marras G; Graham DY
    Scand J Gastroenterol; 2016 Nov; 51(11):1281-7. PubMed ID: 27381266
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma.
    Sawas T; Zamani SA; Killcoyne S; Dullea A; Wang KK; Iyer PG; Fitzgerald RC; Katzka DA
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1709-1718. PubMed ID: 34757196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.